Holen Sie sich die Stockscreener-App
23.50
0.13%
0.03
Handel nachbörslich:
23.56
0.06
+0.26%
Schlusskurs vom Vortag:
$23.47
Offen:
$23.02
24-Stunden-Volumen:
228.24K
Relative Volume:
5.82
Marktkapitalisierung:
$1.01B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.00%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$23.01
$24.36
1-Wochen-Bereich:
$21.71
$24.36
52-Wochen-Spanne:
$21.71
$24.36
Beta Bionics Inc Stock (BBNX) Company Profile
Firmenname
Beta Bionics Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie BBNX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
23.50 | 1.01B | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
129.07 | 224.12B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.25 | 155.19B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
391.40 | 149.44B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.01 | 114.86B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.35 | 41.68B | 6.60B | 4.16B | 490.10M | 6.93 |
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
Eventide Asset Management, LLC Acquires Significant Stake in Bet - GuruFocus.com
Artificial Pancreas Maker Beta Bionics Just Started Trading. Should You Buy BBNX Stock After Its IPO? - Barchart
Beta Bionics: A Sugar Rush For This IPO (NASDAQ:BBNX) - Seeking Alpha
Signals Recap: Ozempic's Latest Approval, EKDA on Reddit, Lilly Stops Relaxin, Beta Bionics IPO, NKF Turns 75, & More... - substack.com
Obesity-drug maker Metsera posts largest gain as IPOs defy market swoon - MSN
Beta Bionics Announces Closing of $234.6 Million Initial - GlobeNewswire
BBNXBeta Bionics, Inc. Latest Stock News & Market Updates - StockTitan
Oil company Infinity Natural Resources debuts IPO amid deregulation push - MSN
4 Firms Guide Pair Of Biotech IPOs Raising $415M Combined - Law360
Beta Bionics raises $204M in IPO - MedTech Dive
Beta Bionics stock opens 29% higher in Nasdaq debut - MSN
Beta Bionics (BBNX) Opens At $22, IPO Priced At $17 By Investing.com - Investing.com Canada
Beta Bionics Goes Public After Raising $204M Upsized Offering - Orange County Business Journal
Bionics Upsized $204M IPO: A Game-Changer for Diabetes Treatment - USA Herald
Beta Bionics raises $204m to kickstart medtech IPO season - Medical Device Network
Beta Bionics Shares Rise in Nasdaq Debut -January 30, 2025 at 12:39 pm EST - Marketscreener.com
Cooley, Latham Steer Beta Bionics' Upsized $204M IPO - Law360
Beta Bionics Rings the Opening Bell - Nasdaq
Insulin delivery device maker Beta Bionics prices further upsized IPO at $17, the high end of the upwardly revised range - Renaissance Capital
Artificial pancreas maker Beta Bionics aims to raise $204M in Nasdaq IPO - MSN
Beta Bionics Set to Revolutionize Diabetes Management with $204 Million IPO! - mivalle.net.ar
Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering - GlobeNewswire
Beta Bionics sets terms for upsized $165M IPO - MSN
Beta Bionics sets terms for upsized $165M IPO (BBNX:Pending) - Seeking Alpha
Beta Bionics targets $695 million valuation in upsized US IPO - MSN
BBNX IPO NewsInsulin delivery device maker Beta Bionics increases deal size by 47% ahead of $165 million IPO - Renaissance Capital
IPO Roundup: Smithfield Foods, Beta Bionics and more - MSN
Obesity-Focused Metsera Leads Biotech Firms Eyeing IPOs - Law360
Beta Bionics targets $114M IPO raise to fund insulin pump development - MedTech Dive
Beta Bionics, Inc. (BBNX) Announces January 30th IPO - Defense World
Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing - MSN
Beta Bionics Targets $113 Million in IPO, Plans Nasdaq Listing - GuruFocus.com
Beta Bionics sets terms for upsized $113M IPO - MSN
S&P 500 Growth (IGX) QuotePress Release - The Globe and Mail
Beta Bionics Announces Plans for IPO - Orange County Business Journal
Beta Bionics Aims For IPO To Cover Heavy Losses (BBNX) - Seeking Alpha
Beta Bionics, maker of ‘bionic pancreas,’ files for IPO - MedTech Dive
Oilfield Services Firm Flowco Set to Drill Down On $392M IPO - Law360
Beta Bionics Files Registration Statement for Proposed Initial Public Offering - GlobeNewswire
Beta Bionics Raises $60M Series E - Orange County Business Journal
Beta Bionics Announces Closing of a $60 Million Series E Financing - Newswire
Diabetes Dialogue: Diabetes Tech Updates in October 2024 - MD Magazine
Beta Bionics Announces Launch of the iLet Bionic Pancreas With Abbott’s FreeStyle Libre 3 Plus Sensor - Newswire
Abbott expands pump partnerships, launches Lingo CGM - BioWorld Online
Beta Bionics Announces Partnership With Abbott to Integrate the iLet Bionic Pancreas With the FreeStyle Libre 3 Plus iCGM - Yahoo Finance
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics - Business Wire
Beta Bionics’ iLet bionic pancreas launches worldwide - Medical Device Network
First AID positions Dexcom for healthy new year - BioWorld Online
Beta Bionics Announces iLet Bionic Pancreas Is Now Added to the Express Scripts National Commercial Formularies - Newswire
Beta Bionics Secures $100M in Series D - MPO-mag
Beta Bionics closes $100M Series D to support bionic pancreas - Drug Delivery Business News
Finanzdaten der Beta Bionics Inc-Aktie (BBNX)
Es liegen keine Finanzdaten für Beta Bionics Inc (BBNX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Beta Bionics Inc-Aktie (BBNX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mensinger Mike | Chief Product Officer |
Jan 31 '25 |
Sale |
17.00 |
13 |
221 |
25,669 |
| Wellington Hadley Harbor Aggre | 10% Owner |
Jan 31 '25 |
Buy |
17.00 |
1,000,000 |
17,000,000 |
3,901,599 |
1.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):